Literature DB >> 24806109

Distress intolerance, kynurenic acid, and schizophrenia.

Daniel C Javitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24806109      PMCID： PMC4406346          DOI： 10.1001/jamapsychiatry.2014.518

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  10 in total

1.  Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Authors:  Hui-Qiu Wu; Masahiro Okuyama; Yasushi Kajii; Ana Pocivavsek; John P Bruno; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

Authors:  Ikwunga Wonodi; O Colin Stine; Korrapati V Sathyasaikumar; Rosalinda C Roberts; Braxton D Mitchell; L Elliot Hong; Yasushi Kajii; Gunvant K Thaker; Robert Schwarcz
Journal:  Arch Gen Psychiatry       Date:  2011-07

Review 3.  The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease.

Authors:  S Mechiel Korte; Jaap M Koolhaas; John C Wingfield; Bruce S McEwen
Journal:  Neurosci Biobehav Rev       Date:  2004-12-10       Impact factor: 8.989

Review 4.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission.

Authors:  Maurizio Popoli; Zhen Yan; Bruce S McEwen; Gerard Sanacora
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

5.  Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction.

Authors:  K Altman; O Greengard
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

Review 6.  Kynurenines in the mammalian brain: when physiology meets pathology.

Authors:  Robert Schwarcz; John P Bruno; Paul J Muchowski; Hui-Qiu Wu
Journal:  Nat Rev Neurosci       Date:  2012-07       Impact factor: 34.870

7.  Cortisol shifts financial risk preferences.

Authors:  Narayanan Kandasamy; Ben Hardy; Lionel Page; Markus Schaffner; Johann Graggaber; Andrew S Powlson; Paul C Fletcher; Mark Gurnell; John Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

8.  Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Authors:  Joshua Chiappelli; Ana Pocivavsek; Katie L Nugent; Francesca M Notarangelo; Peter Kochunov; Laura M Rowland; Robert Schwarcz; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

Review 9.  The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.

Authors:  C Lavebratt; S Olsson; L Backlund; L Frisén; C Sellgren; L Priebe; P Nikamo; L Träskman-Bendz; S Cichon; M P Vawter; U Osby; G Engberg; M Landén; S Erhardt; M Schalling
Journal:  Mol Psychiatry       Date:  2013-03-05       Impact factor: 15.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.